Maud Beillat
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Cost-utility analysis of second line acromegaly treatment in France.
Journal: Annales d'endocrinologie
Published: May 26, 2025
A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population.
Journal: Infectious diseases and therapy
Published: May 23, 2025
Impact of delaying PCV20 implementation in France's pediatric national immunization program: A population-based Markov model.
Journal: Infectious diseases now
Published: December 20, 2024
Clinical and Economic Burden of Patients With Haemophilia A and B in France: Analysis of a Nationwide Claims Database.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 04, 2024
Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires.
Journal: Frontiers in public health
Published: May 02, 2023
Modeling the public health impact of voxelotor in the management of sickle cell disease in France.
Journal: PloS one
Published: March 20, 2023
Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: July 21, 2020
Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam.
Journal: Frontiers in public health
Published: May 14, 2020
Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY.
Journal: International clinical psychopharmacology
Published: March 03, 2017
Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
Journal: PloS one
Published: November 30, 2016
Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis.
Journal: Drugs in context
Published: August 01, 2016
Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate.
Journal: The international journal of neuropsychopharmacology
Published: July 28, 2016
Last Updated: 09/26/2026